Tonix Pharmaceuticals Holding Corp (TNXP)
0.172
-0.01
(-5.13%)
USD |
NASDAQ |
May 10, 16:00
0.172
0.00 (0.00%)
After-Hours: 18:30
Tonix Pharmaceuticals Enterprise Value: 1.285M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.285M |
| May 08, 2024 | 0.922M |
| May 07, 2024 | 2.498M |
| May 06, 2024 | 2.498M |
| May 03, 2024 | 1.495M |
| May 02, 2024 | 0.3105M |
| May 01, 2024 | 0.8743M |
| April 30, 2024 | 1.104M |
| April 29, 2024 | 1.113M |
| April 26, 2024 | 0.0621M |
| April 25, 2024 | -0.75M |
| April 24, 2024 | -0.75M |
| April 23, 2024 | -1.056M |
| April 22, 2024 | -1.190M |
| April 19, 2024 | -0.75M |
| April 18, 2024 | -1.037M |
| April 17, 2024 | -0.8073M |
| April 16, 2024 | -1.715M |
| April 15, 2024 | -2.097M |
| April 12, 2024 | -0.5111M |
| April 11, 2024 | 0.2054M |
| April 10, 2024 | 0.6641M |
| April 09, 2024 | 1.734M |
| April 08, 2024 | 1.686M |
| April 05, 2024 | 0.5303M |
| Date | Value |
|---|---|
| April 04, 2024 | 1.820M |
| April 03, 2024 | 2.928M |
| April 02, 2024 | 0.067M |
| April 01, 2024 | 0.0078M |
| March 28, 2024 | -2.324M |
| March 27, 2024 | 8.063M |
| March 26, 2024 | 3.599M |
| March 25, 2024 | 3.189M |
| March 22, 2024 | 4.244M |
| March 21, 2024 | 4.156M |
| March 20, 2024 | 4.953M |
| March 19, 2024 | 4.320M |
| March 18, 2024 | 3.511M |
| March 15, 2024 | 2.778M |
| March 14, 2024 | 3.441M |
| March 13, 2024 | 3.441M |
| March 12, 2024 | 3.306M |
| March 11, 2024 | 5.187M |
| March 08, 2024 | 5.914M |
| March 07, 2024 | 5.838M |
| March 06, 2024 | 5.463M |
| March 05, 2024 | 5.240M |
| March 04, 2024 | 6.184M |
| March 01, 2024 | 5.627M |
| February 29, 2024 | 6.131M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-123.24M
Minimum
Dec 19 2022
570.77M
Maximum
Feb 11 2021
15.69M
Average
0.0238M
Median
Jan 30 2020
Enterprise Value Benchmarks
| PetVivo Holdings Inc | 12.64M |
| Acurx Pharmaceuticals Inc | 24.67M |
| Kezar Life Sciences Inc | -131.45M |
| Allakos Inc | -55.69M |
| RAPT Therapeutics Inc | 2.947M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.32M |
| Revenue (Quarterly) | 3.779M |
| Total Expenses (Quarterly) | 31.11M |
| EPS Diluted (Quarterly) | -0.4661 |
| Gross Profit Margin (Quarterly) | 37.36% |
| Profit Margin (Quarterly) | -723.0% |
| Earnings Yield | -4.78K% |